Literature DB >> 11491419

In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.

C Kollmann1, C Tremblay, F Giguel, T C Chou, M S Hirsch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11491419

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


× No keyword cloud information.
  3 in total

1.  The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates.

Authors:  Nina H Lin; Daniel M Negusse; Rameen Beroukhim; Francoise Giguel; Shahin Lockman; Myron Essex; Daniel R Kuritzkes
Journal:  J Virol Methods       Date:  2010-06-25       Impact factor: 2.014

2.  Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors.

Authors:  Robert W King; Ronald M Klabe; Carol D Reid; Susan K Erickson-Viitanen
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Combination antiretroviral therapy and cell-cell spread of wild-type and drug-resistant human immunodeficiency virus-1.

Authors:  Boghuma Kabisen Titanji; Deenan Pillay; Clare Jolly
Journal:  J Gen Virol       Date:  2017-05-05       Impact factor: 3.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.